- Home
- OSRH vs COCP Comparison
OSRH vs COCP Comparison
Compare OSRH & COCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSRH
- COCP
- Stock Information
- Founded
- OSRH N/A
- COCP 2006
- Country
- OSRH United States
- COCP United States
- Employees
- OSRH N/A
- COCP N/A
- Industry
- OSRH
- COCP Biotechnology: Pharmaceutical Preparations
- Sector
- OSRH
- COCP Health Care
- Exchange
- OSRH Nasdaq
- COCP Nasdaq
- Market Cap
- OSRH 13.2M
- COCP 15.4M
- IPO Year
- OSRH N/A
- COCP N/A
- Fundamental
- Price
- OSRH $0.68
- COCP $1.09
- Analyst Decision
- OSRH
- COCP Strong Buy
- Analyst Count
- OSRH 0
- COCP 1
- Target Price
- OSRH N/A
- COCP $6.00
- AVG Volume (30 Days)
- OSRH 2.0M
- COCP 224.8K
- Earning Date
- OSRH 11-24-2025
- COCP 11-14-2025
- Dividend Yield
- OSRH N/A
- COCP N/A
- EPS Growth
- OSRH N/A
- COCP N/A
- EPS
- OSRH N/A
- COCP N/A
- Revenue
- OSRH $104,735.00
- COCP N/A
- Revenue This Year
- OSRH N/A
- COCP N/A
- Revenue Next Year
- OSRH N/A
- COCP N/A
- P/E Ratio
- OSRH N/A
- COCP N/A
- Revenue Growth
- OSRH N/A
- COCP N/A
- 52 Week Low
- OSRH $0.45
- COCP $1.01
- 52 Week High
- OSRH $13.40
- COCP $3.26
- Technical
- Relative Strength Index (RSI)
- OSRH 51.44
- COCP 45.09
- Support Level
- OSRH $0.63
- COCP $1.06
- Resistance Level
- OSRH $0.82
- COCP $1.30
- Average True Range (ATR)
- OSRH 0.11
- COCP 0.07
- MACD
- OSRH 0.01
- COCP 0.02
- Stochastic Oscillator
- OSRH 38.69
- COCP 38.33
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.
About COCP Cocrystal Pharma Inc.
Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).